Adial Pharmaceuticals
ADIL
0,54 €
Share price
22.57%
Change (1 day)
-44.52%
Change (1 year)
Categories
Adial Pharmaceuticals (ADIL) - Cash on Hand
Cash on Hand as of March 2025 : €2.04 Million
According to Adial Pharmaceuticals
's latest financial reports the company has €2.04 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Adial Pharmaceuticals - Cash on Hand chart (from 2016 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | €3.6 M | |
| 2022-12-31 | €3.73 M | -30.31% |
| 2021-12-31 | €5.35 M | 49.6% |
| 2020-12-31 | €3.57 M | -40.85% |
| 2019-12-31 | €6.04 M | 78.88% |
| 2018-12-31 | €3.38 M | 22137.84% |
| 2017-12-31 | €0.01 M | -81.82% |
| 2016-12-31 | €0.08 M | -43.67% |
| 2015-12-31 | €0.14 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | €2.15 M | 5.76% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | €0.11 M | -94.42% | Bahamas |